2022 annual financial data
Bionano Genomics 2022 Operating margin
Direct answer
Operating margin was -473.7%.
Operating income was -131,698,000 USD and net income was -132,596,000 USD.
Operating cash flow was -124,816,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,802,000 USD
- Operating income
- -131,698,000 USD
- Net income
- -132,596,000 USD
- Operating cash flow
- -124,816,000 USD